Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7075771

N=C(N)NCCCOc1ccc2c(c1)CC(CC(=O)O)CCC2.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 6/20 0.47
ITGA2B P08514 5/20 0.47
KDM4E B2RXH2 2/20 0.44
POLB P06746 1/20 0.44
PPARD Q03181 8/20 0.41
PPARA Q07869 2/20 0.41
PPARG P37231 3/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ITGAV P06756 3/20 0.37
NQO2 P16083 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7073981 0.98 ITGB3 (0.46) ITGB3ITGA2BKDM4EPOLBPPARD
Trifluoroacetic Acid SCHEMBL7071446 0.96 ITGB3 (0.52) ITGB3ITGA2BKDM4EPOLBPPARD
Trifluoroacetic Acid SCHEMBL7075074 0.95 ITGB3 (0.50) ITGB3ITGA2BKDM4EPOLBPPARD
Trifluoroacetic Acid SCHEMBL7071421 0.94 ITGB3 (0.53) ITGB3ITGA2BKDM4EPOLBPPARD
Trifluoroacetic Acid SCHEMBL7073087 0.93 ITGB3 (0.52) ITGB3ITGA2BKDM4EPOLBPPARD
Trifluoroacetic Acid SCHEMBL7079100 0.92 ITGB3 (0.54) ITGB3ITGA2BKDM4EPOLBPPARD
Hydrochloric Acid SCHEMBL7078468 0.92 ITGB3 (0.51) ITGB3ITGA2BKDM4EPOLBPPARD
Trifluoroacetic Acid SCHEMBL7076225 0.91 ITGB3 (0.58) ITGB3ITGA2BKDM4EPOLBPPARD
Trifluoroacetic Acid SCHEMBL7075689 0.90 KDM4E (0.42) ITGB3ITGA2BKDM4EPOLBPPARD
Trifluoroacetic Acid SCHEMBL7075528 0.89 ITGB3 (0.56) ITGB3ITGA2BKDM4EPOLBPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030109523-A1 Bicyclic antagonists selective for the alphavbeta3 integrin WYETH (US) 2003-06-12 US disclosed
US-6429214-B1 INHIBITORS OF BONE RESORPTION WYETH 2002-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109523-A1 Bicyclic antagonists selective for the alphavbeta3 integrin ITGAV, ITGB2, ITGB3 ITGB3 3/4885ITGA2B 7/4885KDM4E 560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.